University of Virginia
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1819-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.virginia.edu
Effect of Nitropaste in Chest Masculinizing Surgery
- First Posted Date
- 2024-05-24
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 256
- Registration Number
- NCT06428669
- Locations
- 🇺🇸
University of Virginia Medical Center, Charlottesville, Virginia, United States
InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy
Not Applicable
Recruiting
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Device: InsuLearn
- First Posted Date
- 2024-05-13
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 10
- Registration Number
- NCT06411548
- Locations
- 🇺🇸
University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, United States
Optical Measurements of the Skin Surface to Infer Distinctions in Myofascial Tissue Stiffness
Not Applicable
Completed
- Conditions
- Tissue Pain
- Interventions
- Other: Soft tissue manipulation
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 5
- Registration Number
- NCT06390085
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Pain Control and Quality of Recovery After Intravenous Methadone Versus Intrathecal Morphine in Major Abdominal Surgery
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 40
- Registration Number
- NCT06387303
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Optimizing a Digital AEP Risk Intervention With Native Women and Communities
Not Applicable
Recruiting
- Conditions
- Contraception UseAlcohol Exposed PregnancyUnplanned PregnancySexual BehaviorAlcohol Use, Unspecified
- Interventions
- Behavioral: Survey
- First Posted Date
- 2024-03-22
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 300
- Registration Number
- NCT06324929
- Locations
- 🇺🇸
University of Virginia Fontaine Research Park, Charlottesville, Virginia, United States
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
Recruiting
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Diagnostic Test: HRCTDiagnostic Test: Blood Draw
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 160
- Registration Number
- NCT06323876
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Text-Based Messaging Strategies for Preventing Subsequent Problematic Alcohol Use
Not Applicable
Recruiting
- Conditions
- Alcohol DrinkingText MessagingBinge Drinking
- Interventions
- Behavioral: Brief Alcohol InterventionBehavioral: Automated and Targeted Text Messages
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 3000
- Registration Number
- NCT06318975
- Locations
- 🇺🇸
JBSA Lackland, San Antonio, Texas, United States
Precision Rifampin Trial for Personalized Dosing
Phase 1
Not yet recruiting
- Conditions
- Tuberculosis
- Interventions
- Diagnostic Test: urine spectrophotometry for rifampin absorbance
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 200
- Registration Number
- NCT06318416
Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke
Recruiting
- Conditions
- Ischemic StrokeCYP2C19 Polymorphism
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 350
- Registration Number
- NCT06292117
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Colchicine in Acutely Decompensated HFREF
Phase 4
Recruiting
- Conditions
- Heart FailureHeart Failure With Reduced Ejection FractionDecompensated Heart Failure
- Interventions
- Drug: Control/Placebo group
- First Posted Date
- 2024-02-29
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 30
- Registration Number
- NCT06286423
- Locations
- 🇺🇸
UVA Health, Charlottesville, Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath